ASP Isotopes (NASDAQ:ASPI – Get Free Report) is one of 17 public companies in the “Miscellaneous chemical products” industry, but how does it compare to its rivals? We will compare ASP Isotopes to similar companies based on the strength of its analyst recommendations, earnings, institutional ownership, valuation, risk, dividends and profitability.
Earnings and Valuation
This table compares ASP Isotopes and its rivals top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| ASP Isotopes | N/A | -$4.95 million | -2.43 |
| ASP Isotopes Competitors | $1.36 billion | $35.79 million | 15.18 |
ASP Isotopes’ rivals have higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| ASP Isotopes | N/A | -116.87% | -90.49% |
| ASP Isotopes Competitors | -21.17% | 0.85% | -7.44% |
Institutional & Insider Ownership
1.5% of ASP Isotopes shares are held by institutional investors. Comparatively, 72.6% of shares of all “Miscellaneous chemical products” companies are held by institutional investors. 14.1% of shares of all “Miscellaneous chemical products” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings for ASP Isotopes and its rivals, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ASP Isotopes | 0 | 0 | 0 | 0 | N/A |
| ASP Isotopes Competitors | 31 | 331 | 309 | 6 | 2.43 |
As a group, “Miscellaneous chemical products” companies have a potential upside of 18.86%. Given ASP Isotopes’ rivals higher probable upside, analysts plainly believe ASP Isotopes has less favorable growth aspects than its rivals.
Summary
ASP Isotopes rivals beat ASP Isotopes on 8 of the 9 factors compared.
ASP Isotopes Company Profile
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
